If you want to study in Australia and just become eligible for PhD studies then you are lucky because University of Queensland (UQ) has announced scholarship for the academic year of 2019 -2020 in any of the available PhD degree program. These scholarships will be awarded under the title of University of Queensland’s PhD Scholarships in Novel Diagnostics, Therapeutics and Theranostics in Australia, 2019 to the hardworking, talented and deserving students. This educational award will provide you a Partial Funding, $32,788 per year depending upon the scholarship you earn. The best track record you have the more coverage you will be able to receive.
The University of Queensland’s Australian Research Council Training Centre for Innovation in Biomedical Imaging Technology (CIBIT) is offering Ph.D. Scholarships in Novel Diagnostics, Therapeutics, and Theranostics to develop Precision Medicine in Cancer.
Eligibility for University of Queensland’s PhD Scholarships in Novel Diagnostics, Therapeutics and Theranostics in Australia, 2019:
- The candidates applying should have a 1st Class Honours degree or Postgraduate degree relevant fields.
- The student can have additional background in subject areas like medicine, biomedicinal Sciences, and fields beneficial to inventing targetted medicine for Cancer.
- The candidate must apply for the Ph.D. program Novel Diagnostics, Therapeutics, and Theranostics.
- Fluency in English both oral and written (required IELTS score).
Documents Required:
- Academic Transcripts.
- Curriculum Vitae (CV).
- Cover Letter.
- IELTS scorecard.
Value of University of Queensland’s PhD Scholarships in Novel Diagnostics, Therapeutics and Theranostics in Australia, 2019:
- Annual stipend of AUD 32,788.
- Stipend is offered for three years with the possible extension of six months.
Deadline for University of Queensland’s PhD Scholarships in Novel Diagnostics, Therapeutics and Theranostics in Australia, 2019:
- The last date to apply for the University of Queensland’s PhD Scholarships in Novel Diagnostics, Therapeutics and Theranostics is 6th January 2019.